Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Johnson and Johnson
McKinsey
Harvard Business School
AstraZeneca

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,729,786

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,729,786
Title: Liquid applicator for coloring a liquid
Abstract:Applicators and a method of coloring a liquid. More specifically, the present invention relates to a liquid applicator having a flexible hollow body within which a liquid-filled, glass ampoule is received. The liquid applicator also has porous element containing colorant positioned such that when the ampoule is fractured, the liquid flows through the porous element containing colorant. Colorant is transferred to the liquid as it flows through the porous element. The resulting colored solution may be applied to the desired surface.
Inventor(s): Tufts; Scott A. (El Paso, TX), Flores; Jesus (El Paso, TX), Guzman; Manuel (El Paso, TX)
Assignee: Mediflex Hospital Products, Inc. (Overland Park, KS)
Application Number:10/388,826
Patent Claim Types:
see list of patent claims
Delivery; Use;

Drugs Protected by US Patent 6,729,786

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-007 Oct 10, 2006 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,729,786

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004220817   Start Trial
Brazil PI0408318   Start Trial
Canada 2519176   Start Trial
European Patent Office 1610961   Start Trial
European Patent Office 3117866   Start Trial
Spain 2601493   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Medtronic
Merck
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.